We started something in 2023. Tired of the usual monochrome, sterile pharma conferences, we decided to make a stronger impact on our industry. The theory was simple: by hosting a space where usually ‘isolated’ creative and innovative minds could find each other, we stand a chance of sparking a more ambitious revolution in pharma. With a commitment to not just listen but to act, we set out to deconstruct and then reconstruct our industry over the course of two days.
In 2024, we’re doing it again, but harder and faster.
Pharmageddon is for the disruptors, the weirdos, the rebels and the outliers. Sometimes those people are senior leaders, but sometimes they’re junior. It is for those who don’t accept the current status, who think our industry is young and full of potential. Those who see a brighter future and are driven to get there.
Whether you’re an EVP or an EA, a service provider or a patient, an HCP or part of the media, you’re welcome so long as you’re willing to get your sleeves rolled up.
Pharmageddon is not a passive learning experience. We are not polite or quiet. This event demands active engagement from every participant.
After Pharmageddon, you’ll leave not just inspired, but also equipped with insights and ideas that could shape the future of healthcare.
Our ‘solve’ sessions challenge attendees to think differently about the future through practical problem-solving exercises and speculative design. These will push boundaries and encourage deeper, collaborative thinking. Everyone contributes, sharing thoughts, exploring new ideas, and voicing concerns.
Emma Sutcliffe Global Patient Officer. VP, Head of Patient Affairs Ipsen
Alexey Cherchago Chief Operating Officer, Europe. Olpha
Alan McDougall Senior Vice President and Head of Medical Affairs, Established Markets Astellas
Georges Dagher VP - BU Head General Medicine GSK
Alejandra Betancourt Global VP Content Excellence and Innovation Novo Nordisk
Anne Sofie Røstbjærg Vice President, Customer Engagement Novo Nordisk
Ole Moelskov Bech Corporate Vice President Novo Nordisk
Catarina Santos Executive Director Launch Excellence Novartis
Carlos Eid Executive Director, International Medical Affairs, CV & ASCVD Novartis
Florent Hassen Global Product Owner - Omnichannel Advanced Analytics Roche
Gabriel de Paula Senior Event Manager +351 914 083 112